- SNOA Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
CORRESP Filing
Sonoma Pharmaceuticals (SNOA) CORRESPCorrespondence with SEC
Filed: 24 Jul 09, 12:00am
Re: | Oculus Innovative Sciences, Inc. File No. 333-158539 |
• | should the Commission or the staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing; | ||
• | the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and | ||
• | the Company may not assert staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States. |
Very truly yours, OCULUS INNOVATIVE SCIENCES, INC. | ||||
By: | /s/ Jim Schutz | |||
Jim Schutz | ||||
Vice President and General Counsel | ||||